OC
NPTN

Oppenheimer & Co’s NEOPHOTONICS CORP NPTN Stock Holding History

Oppenheimer & Co’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-25,000
Closed -$84K – 1505
2014
Q3 		$84K Sell
25,000
-850
-3% -$2.65K ﹤0.01% 1356
2014
Q2 		$107K Buy
+25,850
New +$137K ﹤0.01% 1344
2014
Q1 		– Sell
-10,600
Closed -$75K – 1494
2013
Q4 		$75K Buy
+10,600
New +$70.7K ﹤0.01% 1335

Other funds holding NPTN

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ARM
Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Oppenheimer & Co's NPTN Position: Q4 2014 in Review

Oppenheimer & Co sold out of NEOPHOTONICS CORP (NPTN) in Q4 2014, closing a stake of 25,000 shares — an estimated $84K sold.

Oppenheimer & Co first reported a position in NPTN in Q4 2013 and held it in 3 quarters. The position peaked at $107K in Q2 2014. 41 funds tracked by Wall St. Rank hold NPTN as of Q4 2014.

  • Oppenheimer & Co reported no remaining NEOPHOTONICS CORP position as of Q4 2014 after selling out during the quarter.
  • Oppenheimer & Co sold 25,000 NEOPHOTONICS CORP shares in Q4 2014, an estimated $84K.
  • Oppenheimer & Co first reported a position in NEOPHOTONICS CORP in Q4 2013 and held it in 3 quarters.
  • Oppenheimer & Co's NEOPHOTONICS CORP position peaked at $107K in Q2 2014.
  • 41 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q4 2014.

Based on Oppenheimer & Co's 13F filing for Q4 2014, filed 10 Feb 2015.